Skip to main content
. 2015 Nov 25;81(2):246–255. doi: 10.1111/bcp.12792

Table 5.

Adverse events occurring more than once during the study

Normal renal function (n = 25) Mild renal impairment (n = 12) Moderate renal impairment (n = 12) Total (n = 49)
Adverse events F, n, % F, n, % F, n, % F, n, %
Total 29, 15, 60.0 25, 8, 66.7 2, 2, 16.7 56, 25, 51.0
Headache 8, 4, 16% 6, 5, 42% 14, 9, 18%
Dizziness 5, 4, 33% 1,1, 8% 6, 5, 10%
Diarrhoea 2, 2, 8% 2, 2, 4%
Dry mouth 2, 2, 8% 2, 2, 4%
Fatigue 4, 4, 16% 1, 1, 8% 5, 5, 10%
Feeling hot 2, 2, 17% 2, 2, 4%
Nasopharyngitis 5, 5, 20% 1, 1, 8% 6, 6, 12%
Tinnitus 2, 1,8% 2,1, 2%
Vertigo 2, 2, 17% 2, 2, 4%
Sleep disorder 1,1,4% 1,1,8% 2,2,4%

F, Number of events; n, number of subjects; %, the percent of treated subjects